These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 26233808)

  • 1. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG; Paik NJ; Lee SU; Oh BM; Chun MH; Kwon BS; Bang MS
    PLoS One; 2015; 10(6):e0128633. PubMed ID: 26030192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ; Kwon BS; Park YG
    Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox
    Ye DH; Chun MH; Park YG; Paik NJ; Lee SU; Yoo SD; Kim DY
    Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of MT10107 in post-stroke upper limb spasticity treatment: A phase I randomized controlled trial.
    Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ
    Medicine (Baltimore); 2022 Nov; 101(44):e31367. PubMed ID: 36343044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
    Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
    Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
    Abo M; Shigematsu T; Hara H; Matsuda Y; Nimura A; Yamashita Y; Takahashi K
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
    J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.